Clinical Conversations in MS
Schedule Your Call Today:
View all neurology CME/CE at www.Neurology-IQ.com
Sign up to receive e-mail alerts about our new interactive activities.
Questions? Contact our call center toll-free at 866 858 7434 or e-mail info@med-iq.com. |
BALTIMORE, Md.—June 22, 2012—Advanced practice nurses, nurse practitioners, and physician assistants who care for patients with multiple sclerosis (MS) are invited to speak with nationally recognized MS experts in the new, complimentary CME/CE activity, Clinical Conversations in Multiple Sclerosis.
The 30-minute, individualized AANP-/AAPA-certified teleconferences are designed to review strategies for identifying patients with MS who are appropriate candidates for disease-modifying therapy (DMT). Faculty experts will discuss methods for designing effective treatment plans and monitoring and managing suboptimal response, as well as the potential role of emerging agents in the MS therapeutic landscape; participants will have the opportunity to ask questions about challenging clinical scenarios they face.
"Although significant advances have been made in the understanding of MS, treatment remains challenging due to evolving diagnostic criteria, the lack of definitive guidelines and algorithms to inform treatment decisions, and the limitations of available treatments," said Kathleen Costello, MS, ANP-BC, MSCN, of Johns Hopkins Multiple Sclerosis Center. "Early and ongoing therapy with DMT has been shown to be beneficial, yet identifying appropriate candidates and selecting the appropriate agents can be challenging. During these CME/CE-certified teleconferences, we review the clinical risk-to-benefit ratios of currently available DMTs and explore strategies for evaluating, identifying, and treating suboptimal response."
| Faculty |
| |
Kathleen Costello, MS, ANP-BC, MSCN
Research Associate/Nurse Practitioner
Johns Hopkins Multiple Sclerosis Center
Baltimore, MD
|
|
| |
David T. Dubé, MS, PA-C
OMRF Multiple Sclerosis Center of Excellence
Oklahoma City, OK
|
|
| |
Brant J. Oliver, PhD, NP, MSN, MPH, MSCN
Nurse Practitioner in Neurology & Psychiatry
Director of Clinical Evaluative Sciences Research
Dartmouth-Hitchcock Medical Center
Lebanon, NH
|
|
Interested clinicians can schedule their teleconference by calling (toll-free) 866 858 7434, e-mailing concierge@med-iq.com, or completing this brief online form. Please note: space is limited—register today.
This program is approved for 0.5 contact hour of continuing education by the American Academy of Nurse Practitioners. This program has been reviewed and is approved for a maximum of .5 hours of AAPA Category I CME credit by the Physician Assistant Review Panel. This activity is approved for AMA PRA Category 1 Credit™. This activity is supported by an educational grant from Teva Neuroscience. For more information, call (toll-free) 866 858 7434, e-mail concierge@med-iq.com, or visit www.Med-IQ.com/a642.
|
About Med-IQ
Med-IQ, America’s most respected provider of continuing medical education (CME), inspires healthcare professionals through activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ received the Alliance for Continuing Education in the Health Professions' President’s Award (2012), Award for Outstanding CME Outcomes Assessment (2012), and William Campbell Felch Award for Outstanding Research in CME (2011). Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively. We are a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives. To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, connect with us on LinkedIn, and visit our YouTube channel.
For more information, contact: |
close
